PM&R Meeting Abstracts

Official abstracts site for the AAPM&R Annual Assembly and the PM&R Journal.

MENU 
  • Home
  • Meetings Archive
    • AAPM&R Annual Assembly 2022
    • AAPM&R Annual Assembly 2021
    • AAPM&R Annual Assembly 2020
    • AAPM&R Annual Assembly 2019
  • Resources
  • Advanced Search

Comprehensive, Multimodal Interdisciplinary Approach to Treating CRPS in CYP2D6 Deficient Patient Without Opioids

Kyla Kosidowski (Wayne State University School of Medicine, Detroit, Michigan); David Rustom

Meeting: AAPM&R Annual Assembly 2022

Categories: Pain and Spine Medicine (2022)

Session Information

Session Title: AA 2022 Posters - Pain and Spine Medicine

Session Time: None. Available on demand.

Disclosures: Kyla Kosidowski: No financial relationships or conflicts of interest

Case Diagnosis: This is an occurrence of complex regional pain syndrome following ORIF of right tibial pilon fracture in patient with CYP2D6 deficiency.

Case Description or Program Description: A 26-year-old male with CYP2D6 deficiency presented to the ED with fever and worsening right leg pain two days after ORIF of right tibial pilon fracture. The patient was found to have RLE compartment syndrome and underwent fasciotomy, three I&D’s, and wound closure over the week. The patient was prescribed morphine ER 15mg Q8H, oxycodone 15mg Q4H, and gabapentin 300mg TID upon discharge. He was referred by orthopedics due to continued pain, after they had documented a CYP2D6 deficiency.

Setting: Rehabilitation hospital and outpatient clinic

Assessment/Results: On evaluation the patient’s opioids were discontinued, and Cymbalta, Tizanidine, Tylenol and Gabapentin were prescribed. In therapy we utilized range of motion, desensitization and manual therapies. Eight weeks later he was pain free, weight bearing as tolerated, and off all medications.

Discussion (relevance): CYP2D6 deficiency leads to poor metabolism of drugs that are substrates of the enzyme. Opioids are notable drugs that require sufficient levels of CYP2D6 to be metabolized and thus exhibit analgesic effect. This case is unique in that a CYP2D6 deficient patient’s excruciating pain from CRPS was managed without opioids and instead incorporated a comprehensive, multimodal interdisciplinary approach. This approach led to improved function and complete pain relief over an eight week period.

Conclusions: CYP2D6 deficiency is a rare condition in which individuals poorly metabolize certain drugs including opioids. For individuals with CYP2D6 deficiency, alternatives to opioid treatment are imperative for management of severe pain.

Level of Evidence: Level V

To cite this abstract in AMA style:

Kosidowski K, Rustom D. Comprehensive, Multimodal Interdisciplinary Approach to Treating CRPS in CYP2D6 Deficient Patient Without Opioids [abstract]. PM R. 2022; 14(S1)(suppl 1). https://pmrjabstracts.org/abstract/comprehensive-multimodal-interdisciplinary-approach-to-treating-crps-in-cyp2d6-deficient-patient-without-opioids/. Accessed May 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to AAPM&R Annual Assembly 2022

PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/comprehensive-multimodal-interdisciplinary-approach-to-treating-crps-in-cyp2d6-deficient-patient-without-opioids/

Leading the Way. Baltimore, MD & Virtual. October 20-23, 2022. #aapmr22

PM&R Journal

View issues of PM&R on the Wiley Online Library »

American Academy of Physical Medicine and Rehabilitation

Visit the official site for the American Academy of Physical Medicine and Rehabilitation »

AAPM&R Annual Assembly

Visit the official site for the AAPM&R Annual Assembly »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley